Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04350073 · ClinicalTrials.gov registry record
Longitudinal Energy Expenditure and Metabolic Effects in Patients With COVID-19 (LEEP-COVID)
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 65
- Enrollment target
NCT04350073 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 65 participants.
The verdict
NCT04350073 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 65 participants
- Enrollment target
Study Summary
This current proposal evaluates the Longitudinal Energy Expenditure and Metabolic Effects in Patients with COVID-19 (LEEP-COVID) to understand, guide and optimize our metabolic and nutritional care of these high risk patients. As no data exist for the metabolic effects of COVID-19 patients, this data is urgently needed and essential to assist in the care of COVID-19 patients worldwide. We are uniquely positioned at Duke to perform this research, as we are the only US center with 2 of the FDA-approved devices in existence currently capable of collecting this vital data to guide the care of COVID-19 patients worldwide.
Interventions
- DEVICE Q-NRG Metobolic Cart Device
- DEVICE MuscleSound Ultrasound
- DEVICE Multifrequency Bioimpedance Spectroscopy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2020-04-20 |
| Est. Completion | 2022-08-22 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04350073
The ClinicalTrials.gov registry entry for NCT04350073 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 65 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Q-NRG Metobolic Cart Device is the first listed.
NCT04350073 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04350073 about?
NCT04350073 is a clinical study titled "Longitudinal Energy Expenditure and Metabolic Effects in Patients With COVID-19 (LEEP-COVID)". This current proposal evaluates the Longitudinal Energy Expenditure and Metabolic Effects in Patients with COVID-19 (LEEP-COVID) to understand, guide and optimize our metabolic and nutritional care of these high risk patients. As no data exist for the metabolic effects of COVID-19 patients, this dat...
What is the current status of trial NCT04350073?
This trial is currently completed. The enrollment target is 65 participants. The study started on 2020-04-20. Estimated completion is 2022-08-22.
What interventions are being tested in trial NCT04350073?
The interventions under investigation include: Q-NRG Metobolic Cart Device (DEVICE), MuscleSound Ultrasound (DEVICE), Multifrequency Bioimpedance Spectroscopy (DEVICE).
Who is sponsoring clinical trial NCT04350073?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.